down arrow

Shanghai OPM Biosciences Co. Ltd.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE100005PF1
CNY
53.13
11.58 (27.87%)

Dec 15

SHG

 Click here to see other stocks
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Comparison
Company
Score
Quality
Valuation
Financial
Technical
Shanghai OPM Biosciences Co. Ltd.
Why is Shanghai OPM Biosciences Co. Ltd. ?
1
Poor long term growth as Net Sales has grown by an annual rate of 7.54% and Operating profit at -46.03% over the last 5 years
2
The company has declared positive results in Mar'2025 after 7 consecutive negative quarters
  • NET PROFIT(Q) At CNY 16.86 MM has Grown at 290.99%
  • RAW MATERIAL COST(Y) Fallen by -2.08% (YoY)
  • INVENTORY TURNOVER RATIO(HY) Highest at 2.65%
3
With ROE of 1.54%, it has a fair valuation with a 2.05 Price to Book Value
  • Over the past year, while the stock has generated a return of 22.00%, its profits have fallen by -19.8%
stock-recommendationReal-Time Research Report
Verdict Report
How much should you hold?
  1. Overall Portfolio exposure to Shanghai OPM Biosciences Co. Ltd. should be less than 10%
  2. Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is Shanghai OPM Biosciences Co. Ltd. for you?

High Risk, High Return

Absolute
Risk Adjusted
Volatility
Shanghai OPM Biosciences Co. Ltd.
-100.0%
0.88
52.96%
China Shanghai Composite
12.36%
0.86
14.45%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors
Factor
Value
Sales Growth (5y)
7.54%
EBIT Growth (5y)
-46.03%
EBIT to Interest (avg)
31.48
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.56
Sales to Capital Employed (avg)
0.13
Tax Ratio
57.18%
Dividend Payout Ratio
227.20%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
7.48%
ROE (avg)
4.90%
stock-recommendationValuation
Valuation Scorecard stock-summary
stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary
Factor
Value
P/E Ratio
133
Industry P/E
Price to Book Value
2.05
EV to EBIT
185.95
EV to EBITDA
40.04
EV to Capital Employed
4.05
EV to Sales
8.98
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
2.18%
ROE (Latest)
1.54%
stock-recommendationTechnicals
Technical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Dow Theory
No Trend
Mildly Bearish
OBV
No Trend
Mildly Bearish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
Analyse All Technical Factors stock-recommendation
stock-recommendationFinancial Trend
Financial Trend Scorecard stock-summary
stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

11What is working for the Company
NET PROFIT(Q)

At CNY 16.86 MM has Grown at 290.99%

RAW MATERIAL COST(Y)

Fallen by -2.08% (YoY

INVENTORY TURNOVER RATIO(HY)

Highest at 2.65%

NET SALES(Q)

Highest at CNY 83.04 MM

PRE-TAX PROFIT(Q)

Highest at CNY 25.59 MM

-12What is not working for the Company
NET PROFIT(HY)

At CNY 8.61 MM has Grown at -74.4%

ROCE(HY)

Lowest at 0.76%

DEBT-EQUITY RATIO (HY)

Highest at -53.16 %

Here's what is working for Shanghai OPM Biosciences Co. Ltd.
Net Profit
At CNY 16.86 MM has Grown at 290.99%
over average net sales of the previous four periods of CNY 4.31 MM
MOJO Watch
Near term Net Profit trend is very positive

Net Profit (CNY MM)

Pre-Tax Profit
At CNY 25.59 MM has Grown at 221.89%
over average net sales of the previous four periods of CNY 7.95 MM
MOJO Watch
Near term Pre-Tax Profit trend is very positive

Pre-Tax Profit (CNY MM)

Net Sales
Highest at CNY 83.04 MM
in the last five periods
MOJO Watch
Near term sales trend is positive

Net Sales (CNY MM)

Pre-Tax Profit
Highest at CNY 25.59 MM
in the last five periods
MOJO Watch
Near term Pre-Tax Profit trend is positive

Pre-Tax Profit (CNY MM)

Inventory Turnover Ratio
Highest at 2.65%
in the last five Semi-Annual periods
MOJO Watch
Company has been able to sell its inventory faster

Inventory Turnover Ratio

Raw Material Cost
Fallen by -2.08% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for Shanghai OPM Biosciences Co. Ltd.
Debt-Equity Ratio
Highest at -53.16 % and Grown
In each half year in the last five Semi-Annual periods
MOJO Watch
The company is borrowing more to fund its operations; it's liquidity situation may be stressed

Debt-Equity Ratio

Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."